Baglin, Trevor
Centessa Pharmaceuticals plc,
United Kingdom
2024 Rank: 76592
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1540 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76592 | 87132 |
| Total Cites | 582 | 612 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 37 | 37 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 80 | 80 |
| Total Cites to Single+First Authored Papers | 104 | 107 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 168 | 175 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 513 | 534 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
4.90%
|
|
Baglin, Trevor
Medicxi Ventures LLP,
United Kingdom
2023 Rank: 48157
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1068 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48157 | 51632 |
| Total Cites | 722 | 763 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 37 | 37 |
| Total Cites to Single Authored Papers | 28 | 28 |
| Number of Single+First Authored Papers | 80 | 80 |
| Total Cites to Single+First Authored Papers | 137 | 141 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 221 | 226 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 632 | 662 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
5.37%
|
|
Baglin, Trevor
Medicxi Ventures LLP,
United Kingdom
2022 Rank: 36630
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 954 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36630 | 37969 |
| Total Cites | 798 | 855 |
| H-index | 13 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 37 | 37 |
| Total Cites to Single Authored Papers | 33 | 33 |
| Number of Single+First Authored Papers | 80 | 80 |
| Total Cites to Single+First Authored Papers | 153 | 158 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 244 | 255 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 676 | 714 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.20 |
| Self-Citation Percentage |
6.67%
|
|
Baglin, Trevor
Medicxi Ventures LLP,
United Kingdom
2021 Rank: 36352
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 884 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36352 | 38551 |
| Total Cites | 1233 | 1324 |
| H-index | 17 | 19 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 37 | 37 |
| Total Cites to Single Authored Papers | 35 | 35 |
| Number of Single+First Authored Papers | 80 | 80 |
| Total Cites to Single+First Authored Papers | 237 | 247 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 359 | 378 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1018 | 1080 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.23 |
| Self-Citation Percentage |
6.87%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.